Resource Center

Make advancements with precision biologics tools, designed to enhance your therapeutic approaches encompassing monoclonal antibodies, recombinant proteins, vaccines, and targeted next-generation cell and gene therapies.

A cancer cell is unique from its genetic makeup to its microenvironment.

The recent success of cell and gene therapies has paved the way for the next generation of advanced therapeutics. While challenges remain, cell and gene therapy research is seeing a transformational shift in the way that novel modalities, such as CAR-T, CRISPR, and vectors, are developed and delivered.

Chemiluminescent substrates are important tools in the detection of proteins and nucleic acids.

New drug modalities and targets are enabling us to live longer and healthier lives— but their development is grounded on a deep understanding of disease onset and progression.

The process of drug development comprises all the activities involved in bringing a new drug to market once a lead compound has been identified.

Identify and characterize drug discovery targets with functional genomic screening services. Offering CRISPR knockout, CRISPR activation, CRISPR inhibition, dual screening and RNAi technologies  

From cellular screening and imaging applications to high-throughput screening and genomics-based applications, custom explorer™ G3 integrated workstations

Accelerate your time to market with OEM and custom NGS library prep solutions from Revvity. Collaborate with our experts for flexible, reliable, and innovative products that streamline workflows and deliver reproducible results.

Now you can get your solution to your customers faster with lower development costs.

Drug discovery endeavors require a deep understanding of biological systems and their response to potential therapeutics.

Countless diseases, especially cancer, are highly heterogenous in nature which means a one-drug-fitsall approach isn’t practical for treating or fighting these diseases effectively.

RNA sequencing (RNA-seq) is used to analyze the quantity, and the sequence of all RNA transcripts present in a sample at any given time, which is often referred as transcriptome. 

Single-cell analysis identifies information often overlooked by bulk approaches. We offer solutions for key steps in the single-cell sequencing workflow.

With decades of experience in drug discovery driven by strong customer relationships, Revvity has developed an excellent product portfolio of drug discovery tools for complete solutions serving all parts of the discovery workflow.